Scientific Program

The CHEST Congress 2022 online event scientific program is created in collaboration with the CHEST Italian Delegation and will incorporate the best of CHEST Annual Meeting, including lectures, recent advancements in clinical practice and science. The presenting speakers will feature some of the best minds in chest medicine from around the world.

All times in the program are in CET time zone (GMT+2)

*Please note the program is subject to change

3 February 2022

Hall 4

Hall 2

Hall 3

Hall 4

Hall 1

- Targeted Biologics of Severe Asthma
- Comorbidities in Difficult Asthma
- Selecting the Right Treatment for the Right Patient

Hall 4

- Important Clinical Outcomes in COPD
- Non-Pharmacologic Therapies
- Long-term Non-invasive Ventilation

Hall 2

Hall 2

- Update on Pneumonia Treatment
- Pneumonia in the Immunocompromised Host
- Non-resolving Pneumonia

Hall 3

- Optimal Pharmacotherapy in 2022
- Challenges with the Use of Bronchodilators
- Endobronchial Valve Therapy

Hall 4

- How To Minimize Ventilator Induced Lung Injury?
- Troubleshooting Common Problems in Mechanical Ventilation
- When to Extubate and How Aggressive Should We Be?

18:15-18:45

Hall 1

4 February 2022

- Defining Non-T2 Asthma: What are the Mechanisms?
- Best Management Strategy for Non-T2 Asthma
- Obesity & Asthma

- Classification and Diagnosis Guidelines
- Rare Interstitial Lung Diseases
- Newest Therapeutic Approach

13:45-15:25

- COPD Inflammatory Phenotyping
- Evaluation of Body Composition
- Clinical Approach to Exercise Tolerance in Patients With Advanced COPD

16:10-16:40

16:45-17:15

5 February 2022

- The Evolution of World Symposium of Pulmonary Hypertension: Diagnostics and Treatment
- Pulmonary Hypertension and Lung Transplantation: Group 1 and Beyond

- The Modern Pulmonologist Facing With the Study of Small Airways
- Peculiarities of Respiratory Pattern During Sleep and Exercise in Normal Subjects
- Airflow Limitation. How to Assess and Prevent it in Patients with Chronic Obstructive Diseases

- VTE
- Pulmonary Hypertension Secondary to Lung Disease
- PAH